Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with epstein-barr virus-related lymphomas

Journal of Infectious Diseases

Volumn 199, Issue 8, 2009, Pages 1121-1127

  Besson, Caroline ^a,i   Amiel, Corinne ^b,c   Catherine, Le Pendeven ^b   Plancoulaine, Sabine ^a,d   Bonnardel, Colette ^j   Ranque, Brigitte ^a,d   Abbed, Karim ⁱ   Brice, Pauline ^e   Fermé, Christophe ^k   Carde, Patrice ^k   Hermine, Olivier ^f   Raphael, Martine ⁱ   Bresson, Jean Louis ^g   Nicolas, Jean Claude ^b,c   Gessain, Antoine ^h   Dethe, Guy ^h,j   Abel, Laurent ^a,d,l  

^a INSERM   (France)

^b Section of Radiology   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f Service d'Hématologie Adultes   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h INSTITUT PASTEUR   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

^j INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^k INSTITUT GUSTAVE ROUSSY   (France)

^l Facult Necker   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BURKITT LYMPHOMA; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HERITABILITY; HODGKIN DISEASE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELATIVE; SCHOOL CHILD; VIRUS CAPSID;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; BURKITT LYMPHOMA; CAMEROON; CAPSID PROTEINS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FAMILY; FEMALE; FRANCE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; UGANDA; YOUNG ADULT;

EID: 65649132277     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597424     Document Type: Article

References (32)

1. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4:757-68.
2. de-The G, Geser A, Day NE, et al.Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978; 274:756-61.
3. Mueller N, Evans A, Harris NL, et al.Hodgkin's disease and Epstein- Barr virus: altered antibody pattern before diagnosis. N Engl J Med 1989; 320:689-95.
4. Rigaud S, Fondaneche MC, Lambert N, et al.XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006; 444: 110-4.
5. Eidenschenk C, Dunne J, Jouanguy E, et al.A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am J Hum Genet 2006; 78:721-7.
6. Besson C, Amiel C, Le-Pendeven C, et al.Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives. J Clin Microbiol 2006; 44:47-50.
7. Glaser R, Padgett DA, Litsky ML, et al.Stress-associated changes in the steadystate expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav Immun 2005; 19:91-103.
8. Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA. Is EBV persistence in vivo a model for B cell homeostasis? Immunity 1996; 5:173-9.
9. Evans AS, Kirchhoff LV, Pannuti CS, Carvalho RP, McClelland KE. A case-control study of Hodgkin's disease in Brazil. II. Seroepidemiologic studies in cases and family members.AmJ Epidemiol 1980; 112:609-18.
10. Lin AY, Kingma DW, Lennette ET, et al.Epstein-Barr virus and familial Hodgkin's disease. Blood 1996; 88:3160-5.
11. Besson C, Roetynck S, Williams F, et al.Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study. PLoS ONE 2007; 2:e406.
12. Plancoulaine S, Abel L, Tregouet D, et al.Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res 2004; 64:8782-7.
13. Hollander M, Wolfe DA. Nonparametric statistical methods. New York: Wiley, 1973.
14. Bonney GE. On the statistical determination of major gene mechanisms in continuous human traits: regressive models. Am J Med Genet 1984; 18:731-49.
15. Demenais FM, Bonney GE. Equivalence of the mixed and regressive models for genetic analysis. I. Continuous traits. Genet Epidemiol 1989; 6:597-617.
16. Sampogna F, Demenais F, Hochez J, et al.Segregation analysis of IgE levels in 335 French families (EGEA) using different strategies to correct for the ascertainment through a correlated trait (asthma). Genet Epidemiol 2000; 18:128-42.
17. Ranque B, Alcais A, Thuc NV, et al.A recessive major gene controls the Mitsuda reaction in a region endemic for leprosy. J Infect Dis 2005; 192: 1475-82.
18. Demenais F, Lathrop GM. REGRESS: a computer program including the regressive approach into the LINKAGE programs [abstract]. Genet Epidemiol 1994; 11:291.
19. Mutalima N, Molyneux E, Jaffe H, et al.Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS ONE 2008; 3:e2505.
20. Gratama JW, Oosterveer MA, Klein G, Ernberg I. EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families. J Virol 1990; 64:4703-8.
21. Okano M, Mizuno F, Osato T. Epstein-Barr virus (EBV) hypersensitivity of peripheral B lymphocytes in patients with EBV genome-positive Burkitt's lymphoma. J Infect 1995; 31:15-9.
22. Yao QY, Tierney RJ, Croom-Carter D, et al.Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J Virol 1996; 70:4884-94.
23. Sitki-Green D, Covington M, Raab-Traub N. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol 2003; 77:1840-7.
24. Hatagima A, Cabello PH, Krieger H. Causal analysis of the variability of IgA, IgG, and IgM immunoglobulin levels. Hum Biol 1999; 71:219-29.
25. Marazita ML, Lu H, Cooper ME, et al.Genetic segregation analyses of serum IgG2 levels. Am J Hum Genet 1996; 58:1042-9.
26. Sumaya CV, Ench Y. Epstein-Barr virus infections in families: the role of children with infectious mononucleosis. J Infect Dis 1986; 154:842-50.
27. Evans AS, Gutensohn NM. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int J Cancer 1984; 34:149-57.
28. Goldin LR, Pfeiffer RM, Gridley G, et al.Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 2004; 100:1902-8.
29. Diepstra A, Niens M, Vellenga E, et al.Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barrvirus- negative Hodgkin's lymphoma. Lancet 2005; 365:2216-24.
30. Niens M, Jarrett RF, Hepkema B, et al.HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV- Hodgkin lymphoma. Blood 2007; 110:3310-5.
31. Salawu L, Fatusi OA, Kemi-Rotimi F, Adeodu OO, Durosinmi MA. Familial Burkitt's lymphoma in Nigerians. Ann Trop Paediatr 1997; 17: 375-9.
32. Jones EH, Biggar RJ, Nkrumah FK, Lawler SD. HLA-DR7 association with African Burkitt's lymphoma. Hum Immunol 1985; 13:211-7.